Please login to the form below

Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique partner to the industry.

With over 15 years of relevant experience we have built an industry-wide reputation for excellence in delivery. Envision provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Our solutions go beyond just providing software. We ensure that we fully understand your business needs, how best to engage with your teams and partners, help solve your problems and improve your performance, and work closely with you to define and address your future challenges.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support.

Areas of Expertise

As a full-service global medical strategy and communications agency we help medical affairs teams to manage projects, publications, information, and data effectively and efficiently.

iEnvision is the new advanced platform for business transformation, operational excellence, and connectivity across the pharmaceutical product life cycle – purpose-built to help plan and manage evidence generation, communication, and grants programs.

Press Releases

Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry: Collaboration capitalizes on Alucio’s flagship Beacon platform and Envision’s global leadership in medical strategy and healthcare communications
Envision Pharma Group appoints Head of Envision Value & Access: Envision Pharma Group is pleased to announce the appointment of Mel Formica as its Head of Envision Value & Access.
Envision Pharma Group appoints new CEO: Meg Heim named as its new Chief Executive Officer
Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform: Smart Citations will feature in Library, Datavision®, and Scientific Communication Platform modules
Envision Pharma Group expands capabilities with specialist behavioral science offering Envision the Change
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry: Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in real-world evidence (RWE)
Paul Archer promoted to Chief Commercial Strategy Officer, Envision Pharma Group: Key Appointment News
Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role: Key Appointment News
Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform: doDOC is a leader in document collaborative review, editing, and authoring
Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions: Goel will drive the development of innovative technologies, and joins Envision from IQVIA where he served as the VP of Technology Solutions
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering: Acquisition follows increased investment in Envision from GHO Capital and its partners
GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth: Move set to advance Envision’s global ambition to be the leading strategic partner in medical affairs
Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020: The PM Society Digital Awards 2020 saw Envision pick up two Silver awards for Congress, Meetings & Events and for Innovation – Creativity as a result of its “See through diabetes” work in collaboration with Mundipharma.
90TEN acquired by Envision Pharma Group: 90TEN’s award-winning behavioral science-led communications group will help deliver a deeper and more diversified offering to Envision’s clients, while bringing significant geographical expansion opportunities for the London-based team.
Envision Pharma Group ranked in Top 10 of the fastest-growing UK companies in pharma: Envision has achieved sixth position in the annual ranking of the UK’s Top 50 fastest-growing privately owned pharma businesses.

White Papers and Resources

The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact

Videos and Podcasts

Latest Tweets

Tweets by @EnvisionPharma

Awards

Gold
Communiqué Awards
Writing Excellence (ED Society)

Gold
PM Society Awards
Exhibitions & Events (Mundi ERS)

Gold
PM Society Digital Awards
Exhibitions & Events (Mundi ERS)

Runners Up (Silver)
BMA Awards (ED Society)
Equality, Diversity and Inclusion

Silver
PM Society Digital Awards
Innovation (Mundi ERS)

Bronze
PM Society Awards
Innovation (Mundi ERS)